You are here: Industry Insights > COVID-19

News List

Lopinavir-ritonavir not an effective treatment for COVID-19, study shows europeanpharmaceuticalreview
October 16, 2020
A clinical trial in the UK has shown that lopinavir-ritonavir is not an effective treatment for patients admitted to hospital with COVID-19.
Lactiga and Mount Sinai sign pact to advance its patented biologic for COVID-19 treatment expresspharma
October 16, 2020
The collaborative team secured an NIH R01 Emergency Award of $2 million dollars to expand this study.
Remdesivir alone or in combination with other drugs considered most promising drug for COVID-19: Poll pharmaceutical-technology
October 16, 2020
The COVID-19 infection caused by the SARS-CoV-2 currently does not have any treatment although several existing approved drugs are being used to treat the disease symptoms.
Confidence in reliability of data regarding COVID-19 therapies remains moderately high: Poll pharmaceutical-technology
October 16, 2020
The need for a therapy to combat the contagious coronavirus disease (COVID-19) has led pharmaceutical companies to fast-track development plans, raising concerns over safety data.
Rigel, Inova Enrolls First Patients in Fostamatinib Trial for Hospitalized COVID-19 Patients americanpharmaceuticalreview
October 16, 2020
Rigel Pharmaceuticals announced enrollment of the first patients in a multicenter, Phase 2 trial to evaluate the safety of fostamatinib, Rigel's oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of hospitalized COVID-19 patients.
LamPORE Test for SARS-CoV-2 Gains CE-IVD Mark americanpharmaceuticalreview
October 16, 2020
LamPORE is a new, rapid, scalable, accurate test, for the detection of the SARS-CoV-2 virus that causes COVID-19. LamPORE is designed to be performed on a desktop device, GridION, or a palm-sized device, MinION Mk1C.
Redhill expands manufacturing for COVID-19 candidate pharmatimes
October 16, 2020
Redhill Biopharma has announced partnerships with two specialist pharmaceutical manufacturers in Europe and Canada to increase manufacturing for its COVID-19 candidate opaganib.
Celltrion COVID-19 antibody treatment to enter Phase III trial europeanpharmaceuticalreview
October 16, 2020
Celltrion Group’s CT-P59 antibody will be tested as a COVID-19 prophylactic in a Phase III clinical trial.
Popular COVID-19 conspiracies linked to vaccine 'hesitancy' worldpharmanews
October 16, 2020
A new study of beliefs and attitudes toward COVID-19 in five different countries - UK, US, Ireland, Mexico and Spain - has identified how much traction some prominent conspiracy theories have within these populations.
COVID-19 clinical trial disruption declines but trials continue to suffer from slow recruitment expresspharma
October 15, 2020
Trials impacted by enrolment suspension have been on a downward trajectory, while the number of clinical trials with delayed initiation have remained steady.